The transaction has been recently approved by Romania’s Competition Council, too.
“On one hand, the partnership with AGISTA helps us further focus on what we do best – assisting patients in need of specialized medical recovery. On the other hand, we will now do this with the conviction that we have a strong team behind us, helping us grow as a business, seize growth opportunities as they arise and make the best decisions for the future of Centrokinetic,” said Bogdan Andrei, Medical Director and Founder of Centrokinetic.
Centrokinetic currently operates three clinics, all in capital city Bucharest, and is preparing for the launch of two more clinics by the end of 2023, marking the expansion of the Centrokinetic network outside of Bucharest.
In 2022, Centrokinetic, established by orthopedic doctor Andrei Bogdan seven years ago, posted more than EUR4.5 million revenue and EUR600,000 EBITDA.
Centrokinetic offers a wide range of medical recovery services for adults and children, with a team of over 110 doctors and therapists specialized in orthopedic and neurological conditions, with three clinics located in Bucharest.
“As part of this transaction, AGISTA’s objectives include consolidating the medical network nationally, aiming to expand to over ten locations nationwide in the next four years. We also aim to identify personalized solutions for the network development, business networking and group synergies,” said Dragos Darabut, Senior Investment Manager at AGISTA, who specializes in investments in the medical sector.
The Agista growth investment fund, a brand launched by Impetum Group, supports with capital and know-how those Romanian SMEs whose products and services are or become essential for society. As a minority shareholder, Agista invests tickets between EUR2 million – EUR5 million and acts as an anchor investor, with a strategic role, having a representative on the board of the companies in the portfolio, contributing to their rapid and healthy development.
“The completion of the transaction marks the first step toward what is already shaping up to be a successful partnership in the medical industry. Centrokinetic is the right fit for us at AGISTA; the industry is specific with tremendous growth potential, and its founder, Dr. Bogdan Andrei, shares a similar vision. He especially aims to take his business to the next level. AGISTA’s team has demonstrated their expertise in navigating this stage, showing their readiness to identify the most suitable market opportunities in building a robust portfolio,” said Nick Kovacs, CEO of AGISTA.